-
GERM Dashboard
- Holdings
ETFMG Treatments Testing and Advancements ETF
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
Mount Vernon Liquid Assets Portfolio, LLC | 3.83 mm | 3.83 mm shares | 29.95 | Short-term investment vehicle | Long | USA |
MRNA Moderna, Inc. | 872.47 k | 8.77 k shares | 6.83 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 775.59 k | 4.05 k shares | 6.07 | Common equity | Long | USA |
BNTX BioNTech SE | 716.51 k | 6.79 k shares | 5.61 | Common equity | Long | Germany |
LH Laboratory Corporation of America Holdings | 714.37 k | 3.14 k shares | 5.59 | Common equity | Long | USA |
DGX Quest Diagnostics Incorporated | 684.85 k | 4.97 k shares | 5.36 | Common equity | Long | USA |
IBRX ImmunityBio, Inc. | 619.94 k | 123.50 k shares | 4.85 | Common equity | Long | USA |
IMCR Immunocore Holdings plc | 588.85 k | 8.62 k shares | 4.61 | Common equity | Long | UK |
PCVX Vaxcyte, Inc. | 551.26 k | 8.78 k shares | 4.31 | Common equity | Long | USA |
QDEL QuidelOrtho Corporation | 487.30 k | 6.61 k shares | 3.81 | Common equity | Long | USA |
BIO Bio-Rad Laboratories, Inc. | 481.11 k | 1.49 k shares | 3.76 | Common equity | Long | USA |
DVAX Dynavax Technologies Corporation | 458.17 k | 32.77 k shares | 3.58 | Common equity | Long | USA |
ZLAB Zai Lab Limited | 455.13 k | 16.65 k shares | 3.56 | Common equity | Long | China |
ABCL AbCellera Biologics Inc. | 420.09 k | 73.57 k shares | 3.29 | Common equity | Long | Canada |
VIR Vir Biotechnology, Inc. | 343.12 k | 34.11 k shares | 2.68 | Common equity | Long | USA |
BCRX BioCryst Pharmaceuticals, Inc. | 311.05 k | 51.93 k shares | 2.43 | Common equity | Long | USA |
OPK OPKO Health, Inc. | 295.96 k | 196.00 k shares | 2.32 | Common equity | Long | USA |
CVAC CureVac N.V. | 239.02 k | 56.77 k shares | 1.87 | Common equity | Long | Germany |
FLGT Fulgent Genetics, Inc. | 217.20 k | 7.51 k shares | 1.70 | Common equity | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 213.62 k | 6.78 k shares | 1.67 | Common equity | Long | USA |
ICVX Icosavax Inc | 200.15 k | 12.70 k shares | 1.57 | Common equity | Long | USA |
HLVX HilleVax, Inc. | 197.11 k | 12.28 k shares | 1.54 | Common equity | Long | USA |
ADPT Adaptive Biotechnologies Corporation | 179.86 k | 36.71 k shares | 1.41 | Common equity | Long | USA |
ANTX AN2 Therapeutics, Inc. | 154.52 k | 7.54 k shares | 1.21 | Common equity | Long | USA |
ALT Altimmune, Inc. | 153.26 k | 13.62 k shares | 1.20 | Common equity | Long | USA |
OSUR OraSure Technologies, Inc. | 152.77 k | 18.63 k shares | 1.20 | Common equity | Long | USA |
NVAX Novavax, Inc. | 144.57 k | 30.12 k shares | 1.13 | Common equity | Long | USA |
IVVD Invivyd, Inc. | 110.00 k | 27.92 k shares | 0.86 | Common equity | Long | USA |
ABUS Arbutus Biopharma Corporation | 106.30 k | 42.52 k shares | 0.83 | Common equity | Long | USA |
SIGA SIGA Technologies, Inc. | 100.94 k | 18.02 k shares | 0.79 | Common equity | Long | USA |
ABBV AbbVie Inc. | 95.15 k | 614.00 shares | 0.74 | Common equity | Long | USA |
First American Government Obligations Fund | 94.80 k | 94.80 k shares | 0.74 | Short-term investment vehicle | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 93.10 k | 106.00 shares | 0.73 | Common equity | Long | USA |
MRK Merck & Co., Inc. | 92.99 k | 853.00 shares | 0.73 | Common equity | Long | USA |
SNY Sanofi | 92.95 k | 1.87 k shares | 0.73 | Common equity | Long | France |
GILD Gilead Sciences, Inc. | 92.43 k | 1.14 k shares | 0.72 | Common equity | Long | USA |
ABT Abbott Laboratories | 92.24 k | 838.00 shares | 0.72 | Common equity | Long | USA |
AZN AstraZeneca PLC | 91.12 k | 1.35 k shares | 0.71 | Common equity | Long | UK |
GSK GSK plc | 89.98 k | 2.43 k shares | 0.70 | Common equity | Long | UK |
JNJ Johnson & Johnson | 88.56 k | 565.00 shares | 0.69 | Common equity | Long | USA |
TAK Takeda Pharmaceutical Company Limited | 88.13 k | 6.18 k shares | 0.69 | Common equity | Long | Japan |
HOLX Hologic, Inc. | 87.60 k | 1.23 k shares | 0.69 | Common equity | Long | USA |
LLY Eli Lilly and Company | 86.27 k | 148.00 shares | 0.67 | Common equity | Long | USA |
PFE Pfizer Inc. | 82.57 k | 2.87 k shares | 0.65 | Common equity | Long | USA |
AVIR Atea Pharmaceuticals, Inc. | 64.52 k | 21.16 k shares | 0.50 | Common equity | Long | USA |
RENB Renovaro Biosciences Inc. | 53.61 k | 16.91 k shares | 0.42 | Common equity | Long | USA |
CRMD CorMedix Inc. | 52.25 k | 13.90 k shares | 0.41 | Common equity | Long | USA |
ENTA Enanta Pharmaceuticals, Inc. | 50.24 k | 5.34 k shares | 0.39 | Common equity | Long | USA |
GRTSQ Gritstone bio, Inc. | 49.31 k | 24.17 k shares | 0.39 | Common equity | Long | USA |
OCGN Ocugen, Inc. | 37.39 k | 65.03 k shares | 0.29 | Common equity | Long | USA |
INO Inovio Pharmaceuticals, Inc. | 35.30 k | 69.21 k shares | 0.28 | Common equity | Long | USA |
CVM CEL-SCI Corporation | 34.47 k | 12.67 k shares | 0.27 | Common equity | Long | USA |
EBS Emergent BioSolutions Inc. | 31.52 k | 13.14 k shares | 0.25 | Common equity | Long | USA |
XBIT XBiotech Inc. | 30.87 k | 7.72 k shares | 0.24 | Common equity | Long | USA |
CUE Cue Biopharma, Inc. | 30.20 k | 11.44 k shares | 0.24 | Common equity | Long | USA |
VAXX Vaxxinity, Inc. | 27.32 k | 32.14 k shares | 0.21 | Common equity | Long | USA |
IFRX InflaRx N.V. | 24.33 k | 14.93 k shares | 0.19 | Common equity | Long | Germany |
VXRT Vaxart, Inc. | 22.08 k | 38.55 k shares | 0.17 | Common equity | Long | USA |
CMRX Chimerix, Inc. | 21.69 k | 22.54 k shares | 0.17 | Common equity | Long | USA |
ENZ Enzo Biochem, Inc. | 17.79 k | 12.80 k shares | 0.14 | Common equity | Long | USA |
HLTHQ Cue Health Inc. | 6.37 k | 39.21 k shares | 0.05 | Common equity | Long | USA |
Gurnet Point Capital LLC
|
1.32 k | 16.56 k shares | 0.01 | Common equity | Long | USA |
SCLX Scilex Holding Company | 1.18 | 0.58 shares | 0.00 | Common equity | Long | USA |
MJNE MJ Holdings, Inc. | 0.00 | 0.00 shares | 0.00 | Common equity | Long | USA |